|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Masimo Corporation (MASI) Reports Third Quarter 2012 Financial Results; Board Declares Special Cash Dividend of $1.00 per Share
11/2/2012 9:29:08 AM
IRVINE, Calif., Nov. 1, 2012 /PRNewswire/ --
Q3 2012 Highlights (compared to Q3 2011):
Product revenue rose 15% to $112.1 million
Masimo rainbow^® revenue rose 41% to $11.0 million, including 92% increase
in SpHb^® revenue
Shipped 33,100 Masimo SET^® and Masimo rainbow^® SET units
Net income was $13.8 million, with EPS of $0.24
Masimo (NASDAQ: MASI) today announced its financial results for the third
quarter ended September 29, 2012, and that its Board of Directors has declared
a special cash dividend of $1.00 per share, payable on December 11, 2012 to
stockholders of record as of the close of business on November 27, 2012.
|
|
|
|
|
|
|
|
|
|
|